CCL19 and pachyonychia congenita: Compared with conventional CAR-T cells, anti-MSLN CAR-T cells coexpressing IL-7 and CCL19 exhibited greater expansion and migration ability in vitro and demonstrated greater inhibition of tumor growth in PC and human mesothelioma mouse models.